Brief: Trevi Therapeutics Q4 Net Income USD -8.316 Million
17/03/2026 20:05
Mar 17 (Reuters) - Trevi Therapeutics Q4 pretax profit USD -8.332 million. Q4 income from operations USD -10.22 million Q4 EPS USD -0.06 Q4 operating expenses USD 10.22 million
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million